Cognoa licenses Stanford's AI behavioral intervention technology for its ASD digital diagnostic device
Cognoa exclusively licensed Stanford University School of Medicine's wearable artificial intelligence (AI)-powered behavioral intervention technology to accelerate development and worldwide commercialization of the company's own digital diagnostic and therapeutic device for children with autism spectrum disorder (ASD), a developmental disability that can cause significant social, communication, and behavioral challenges.
- Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
- Artificial Intelligence
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.